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ABSTRACT
Objective: Surgical correction of the deformity and plaque caused by Peyronie’s disease has
some important disadvantages and extracorporeal shockwave therapy (ESWT) emerged as a new
promising therapy. We evaluated prospectively the efficacy and safety of the association of high dose
vitamin E and ESWT as a non-invasive treatment for the disease.
Materials and Methods: Twenty-five patients 42 to 68 years old (mean = 54) presenting
penile deviation and sexual distress caused by Peyronie’s disease were treated in a non-invasive man-
ner. The time of penile deviation ranged from 16 to 52 months (mean = 30). All patients had previous
unsuccessful treatment for Peyronie’s disease. The angulation’s deformity of the penis was assessed
by photography at home. The patients received vitamin E (l.200 mg daily) during 3 months and
underwent 3 to 6 sessions (mean = 3) of ESWT (3,000 to 4,000 shockwaves) at a power level of l to
2 at 1-week intervals.
Results: From 25 patients treated, 16 (64%) reported an improvement in penile angulation,
with a mean reduction of 21 degrees (10 to 40). Eight patients reported improvement in their sponta-
neous erections. Overall, the patients presented only minimal bruising at the site of treatment and skin
hematoma. Four patients presented urethral bleeding. The mean angulation after treatment in the
control group was 48.67 degrees (30 - 70) and in the study group was 24.42 degrees (0 - 70), statisti-
cally significant.
Conclusion: Considering the common complications and the unsatisfactory outcome of the
surgical correction for Peyronie’s disease, the association of high dose vitamin E and ESWT repre-
sents a good option for a non-invasive, effective and safe treatment of the penile deformity.
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INTRODUCTION
Peyronie’s disease refers to acquired penile
deformities during erection (curvature, indentation,
hourglass or shortening). Peyronie’s disease is char-
acterized by fibrotic plaques of the tunica albuginea
of the penis (1). Over 250 years after its first descrip-
tion, the etiology of the Peyronie’s lesion remains
unclear. The most accepted hypothesis is that the
Peyronie’s plaques are caused by aberrant wound
healing and scar formation, due to consecutive trauma
during intercourse (2-4). Penile deviation is one re-
sult of the inelastic plaque, limiting extensibility of
the penile shaft and causing an angled erection (5).
The symptomatic incidence of Peyronie’s disease has
been estimated at 1%. In white men, the average age
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at onset of Peyronie’s disease is 53 years. The as-
ymptomatic prevalence is estimated at 0.4% to 1.0%.
In another study with 100 men without known
Peyronie’s disease, 22% on autopsy were found to
have fibrotic lesions of the tunica albuginea compat-
ible with Peyronie’s disease (6-9).
Peyronie’s disease may cause significant dis-
tress, affecting the quality of life of both the patient
and his partner. Psychological effects associated with
the disease were reported by 77% of patients (7). Be-
sides, there is a clearly suggestion that the clinical in-
cidence of Peyronie’s disease is increasing (10). Prob-
ably, this increase is associated and seems to coincide
with the use of erection-enhancing medications. Al-
though Peyronie’s disease is characterized as a gradual
spontaneous resolution process, certain features are as-
sociated with a lack of spontaneous resolution, includ-
ing greater than 2-year duration. The treatment may be
clinical or surgical. Oral systemic agents include po-
tassium p-amino benzoate, tamoxifen, acetyl-L-car-
nitine, colchicines and vitamin E (12). On the other
hand, there are quite a lot of surgical procedures to
repair penile deformities; all of them are invasive, with
significant disadvantages to the patient. Recently, en-
couraging results with the extra corporeal shockwave
therapy (ESWT) were reported (12,13).
We prospectively evaluated the association
of high dose vitamin E and ESWT in the treatment of
the penile deviation caused by Peyronie’s disease.
MATERIALS AND METHODS
We studied 40 patients with sexual distress
due to penile deviation caused by Peyronie’s disease.
Patients’ age ranged from 42 to 68 years (mean = 54)
and the time of penile deviation ranged from 16 to 52
months (mean = 30).
Penile pain was referred by 35 patients but it
was not the reason for treatment in any case. Eleven
patients presented mild hypertension, 8 had diabete’s
and 3 have had a radical retropubic prostatectomy.
Fifteen patients presented erectile dysfunction, 7 were
treated with 50 mg of sildenafil, 4 with 20 mg tadalafil,
3 with l0 mg vardenafil, and 1 with intracavernous
injection therapy using tri-mix. All of the 40 patients
were previously treated for the penile deviation with-
out success. The previous therapies were low dose of
vitamin E, tamoxifen, colchicines, potassium p-amino
benzoate and intralesional injections of steroids and
verapamil. All patients refused any kind of surgery.
The angulation of the penis was assessed by
photography during a normal erection at home, and
the diagnosis was confirmed by palpation of the
plaque. The size and site of the plaques were assessed
by ultrasonography.
The patients were divided into 2 groups:
Group - 1, composed of 15 patients that were treated
only by high dose vitamin E (l.200 mg daily) during
3 months, and Group - 2, composed of 25 patients
that received vitamin E and were submitted to ESWT.
The patients underwent 3 to 6 (median = 3) sessions
of ESWT at level-I of intensity, using the Lithostar
Plus machine (Siemens, Germany), with 1-week in-
terval. The accurate delivery of the shockwaves to
the plaques was monitored by a real-time in line ul-
trasound scanner aided by palpation. Treatment re-
sults were assessed by the patient, subjectively. Be-
sides, the objective evaluation was performed by pho-
tographs taken at home, palpation of the plaque and
ultrasonographic measurements.
The results were shown as means and stan-
dard deviations. Two tailed “t” test was used with
Bonferroni correction for statistical comparison. P
value < 0.01 was considered statistically significant.
Trying to predict association between the objective
data and subjective response variable, we used logis-
tic regression.
RESULTS
The treatment was very well tolerated, the
high dosage of vitamin E had no side effects and the
ESWT caused no pain. The use of analgesics was not
necessary. The shock waves therapy presented only
minor complications including penile bruising and
surface bleeding at the point of entry of the shock
waves in 19 patients. Two patients developed ure-
thral bleeding, that settled with conservative treat-
ment. The follow-up ranged from 5 to 13 months
(mean = 8.5). There is no statistical difference be-
tween groups regarding age, diameter (p = 0.089) and
angulation (p = 0.25).
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Of the 25 patients treated, 18 (72%) reported
a significant decrease on the angulation deformity of
the penis (Figure-1). Five patients reported discrete
improvement in the disease and 2 reported no im-
provement in penile angulation. Eight patients re-
ferred improvement in their spontaneous erections.
Eleven patients reported that subjectively the plaque
had diminished. On palpation, the plaques were not
detected in 2 patients and had diminished in other 11
patients.
The ultrasound did not detect five plaques that
remained easily palpable even by the patients. On the
other hand, in seven patients with subjective and pal-
pation improvements the ultrasonographic findings
did not change. One patient, otherwise, reported his
penis was totally straight and had no detectable plaque
either on palpation or on ultrasound (Figure-2).
The mean diameters and the mean angulations
are shown on Tables 1 and 2.
When compared the greater diameter and the
angulation preceding the procedure and after ESWT
there were an important difference in diameter (p =
0.0001) and angulation (p = 0.0001), attesting the
good response of ESWT.
Figures 3 and 4 show the diameter and angle
before and after treatment.
The binary logistic regression showed that
age (p = 0.997, OR = 1), diameter (p = 0.31, OR =
2.2) and angulation (p = 0.697, OR = 0.98) could not
predict good or poor response.
Figure 1  –  A) Penile deviation due to Peyronie’s disease. Be-
fore extracorporeal shockwave therapy.  B) Penile shaft after 3
extracorporeal shockwave therapy sessions.
A
B
Figure 2 – A) Ultrasound showing Peyronie’s plaque. Before
extracorporeal shockwave therapy.  B) Ultrasound after 3 extra-
corporeal shockwave therapy sessions.
A
B
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Group      Angulation       Mean    Standard Deviation
I                    Before            51.33  07.43
                       After             48.67  10.60
II                  Before            54.23  07.83
                       After             24.42               20.80
Table 2 – Angulation (in degrees) assessed by photogra-
phy taken with natural erection at home in the control (I)
and study group (II) before and after treatment.
Figure 3 – Plaque diameter (cm) of patients from control (I) and study (II) groups (mean and standard deviation).
Group   Diameter (cm)    Mean     Standard Deviation
  I             Before             1.08    0.26
                 After             1.03    0.22
  II           Before             1.32    0.61
                 After             0.63    0.37
Table 1 – Diameter analysis by ultrasonography in the
control (I) and study group (II) before and after treatment.
Figure 4 – Penile angulation (degrees) of patients from control (I) and study (II) groups (mean and standard deviation).
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DISCUSSION
Peyronie’s disease has been previously char-
acterized as a process of gradual spontaneous resolu-
tion. However, only 14 % of 97 patients followed
during a 5 years period reported the disorders as re-
solving (11). The pain associated with erection com-
monly resolves with time but the angulation does not.
Peyronie’s disease affects the quality of life of both,
the patient and his partner. Psychological effects due
to Peyronie’s disease are reported by the large major-
ity of patients. The exact cause of the disease is un-
known and most cases are probably idiopathic (8).
Trauma or excessive bending to the erect penis may
result in bleeding into the subtunical spaces making
tunical delamination (2,3). Therefore, trauma is thought
to be the initiating factor in Peyronie’s disease (11).
Whatever the cause might be, the outcome is
the deposition of connective tissue into the tunica al-
buginea of the corpora cavernosa. There is initial
perivascular inflammatory response that infiltrate the
tunica albuginea, followed by the deposition of col-
lagen and fibrin, leading to the penile plaques that
cause the angulation deformity of the penis (14).
Although surgical correction of the angulation
or the plaque is still considered the gold standard for
treating Peyronie’s disease, it certainly presents some
important disadvantages. Some reduction in penile
length and de novo impotence are not uncommon after
surgery (10). As a result, minimally invasive treatments
have been tried, including ortho-voltage radiation, ul-
trasound, short wave diathermy, laser therapy and
shockwave lithotripsy. The exact mechanism of action
of ESWT is still unknown (11) but there are 2 theo-
ries: a direct damage to the plaque (15) and an increased
of vascular density of the area caused by ESWT, lead-
ing to an inflammatory reaction which results in lyses
of the plaque and removal by macrophages (12).
In previous studies, the proportion of pa-
tients showing an improvement in their erection with
ESWT therapy ranged from 47% to 71% (12,13).
We associated vitamin E, a common treatment for
Peyronie’s disease, using the dosage of 1.200 mg
daily (4 times greater than the dose proposal) (2)
and ESWT in the attempt of improving the defor-
mity in a non-invasive way. In this present study, 18
patients (72%) referred improvement in the penile
angulation. However, 8 patients referred improve-
ment in the quality of their spontaneous erections.
There were no major complications. Petechiae, skin
hematoma, penile bruising and urethral bleeding
were the only complications.
CONCLUSION
This initial experience with the association
of high dose of vitamin E and ESWT is an effective
and safe non-invasive treatment for Peyronie’s dis-
ease. Further studies with long-term follow-up are
recommended to confirm the efficacy of this therapy.
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EDITORIAL COMMENT
The authors present a further study on the use
of extracorporeal shock wave therapy (ESWT) for
the treatment of Peyronie’s disease. In contrast to the
most recently published series describing disappoint-
ing results under prospective long-term designs (1,2)
the authors present ESWT as successful method for
treating penile curvatures. These results are also con-
tradictory to the recently published exploratory meta-
analysis of the studies published so far (3). In this
meta-analysis no clear effect of ESWT on penile cur-
vature and plaque size was evident (3)
How could these remarkably differences be
explained? Unfortunately the authors do not discuss
these aspects. In contrast to the previous published in
the literature the authors combined classical ESWT
with the oral administration of high dosage of vita-
min E, four times higher than normal. Could this as-
pect be the key aspect to improve the effect of ESWT?
Regarding to the published literature the use of vita-
min E does not seem effective compared to the natu-
ral history (4,5). Thus it does not seem very reason-
able to combine to ineffective methods for treatment
of Peyronie’s disease that is really a disorder diffi-
cult to cure. However, the data of the present study
seem to be impressive because the only administra-
tion of vitamin E as control group is not effective - as
previously described.
Although ESWT is not favored as standard
treatment by our Peyronie’s study group (2,3) the
authors should be encouraged for further studies of
their concept.
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